Stevens Capital Management’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-11,285
Closed -$49K 873
2017
Q1
$49K Buy
11,285
+731
+7% +$3.38K ﹤0.01% 835
2016
Q4
$54K Buy
+10,554
New +$63.2K ﹤0.01% 833
2016
Q1
Sell
-11,377
Closed -$73K 915
2015
Q4
$73K Buy
+11,377
New +$74.6K ﹤0.01% 868
2015
Q2
Sell
-11,249
Closed -$79K 1044
2015
Q1
$79K Buy
+11,249
New +$92K ﹤0.01% 934
2014
Q4
Sell
-21,047
Closed -$180K 1026
2014
Q3
$180K Sell
21,047
-4,116
-16% -$36.5K 0.01% 877
2014
Q2
$226K Buy
+25,163
New +$226K 0.01% 896
2014
Q1
Sell
-18,253
Closed -$163K 1086
2013
Q4
$163K Buy
+18,253
New +$178K ﹤0.01% 933

Other funds holding CGEN

Stevens Capital Management's CGEN Position: Q2 2017 in Review

Stevens Capital Management sold out of Compugen (CGEN) in Q2 2017, closing a stake of 11,285 shares — an estimated $49K sold.

Stevens Capital Management first reported a position in CGEN in Q4 2013 and held it in 7 quarters. The position peaked at $226K in Q2 2014. 37 funds tracked by Wall St. Rank hold CGEN as of Q2 2017.

  • Stevens Capital Management reported no remaining Compugen position as of Q2 2017 after selling out during the quarter.
  • Stevens Capital Management sold 11,285 Compugen shares in Q2 2017, an estimated $49K.
  • Stevens Capital Management first reported a position in Compugen in Q4 2013 and held it in 7 quarters.
  • Stevens Capital Management's Compugen position peaked at $226K in Q2 2014.
  • 37 funds tracked by Wall St. Rank held Compugen as of Q2 2017.

Based on Stevens Capital Management's 13F filing for Q2 2017, filed 11 Aug 2017.